Stonepine Capital Management, LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:55 pm Sale | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 0 0.000% | -5,438 (Position Closed) | Filing |
| 2021-02-18 7:48 pm Purchase | 2021-01-27 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 5,438 6.900% | 3,322 (+157.03%) | Filing |
| 2021-02-12 5:00 pm Sale | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 2,116 3.800% | -519 (-19.71%) | Filing |